Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma

Fig. 5

The patient who received three courses CK-SBRT. November 2014: The primary abdominal MRI scan with the HCC lesion (in right liver) (a). Then the patient received CK-SBRT with 56Gy/7f. July 2015: MRI scan of 8 months after CK-SBRT (lesion in right liver) (b). The activity of lesion had disappeared. June 2016: MRI scan of lesion right liver after CK-SBRT; New lesion occurred in liver, thereafter the patient received second-course CK-SBRT with 54Gy/6f (c). February 2017: MRI scan of first-treated and second-treated lesion (d). The activity of two lesions had disappeared. November 2017: There was an activity tumor adjacent to first-treated lesion, thereafter the patient underwent 49Gy/7f of CK-SBRT (e). July 2019: MRI scan of the treated area after CK-SBRT (f)

Back to article page